Chicas-Sett, R.; Morales-Orue, I.; Castilla-Martinez, J.; Zafra-Martin, J.; Kannemann, A.; Blanco, J.; Lloret, M.; Lara, P.C.
Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review. Int. J. Mol. Sci. 2019, 20, 2173.
https://doi.org/10.3390/ijms20092173
AMA Style
Chicas-Sett R, Morales-Orue I, Castilla-Martinez J, Zafra-Martin J, Kannemann A, Blanco J, Lloret M, Lara PC.
Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review. International Journal of Molecular Sciences. 2019; 20(9):2173.
https://doi.org/10.3390/ijms20092173
Chicago/Turabian Style
Chicas-Sett, Rodolfo, Ignacio Morales-Orue, Juan Castilla-Martinez, Juan Zafra-Martin, Andrea Kannemann, Jesus Blanco, Marta Lloret, and Pedro C Lara.
2019. "Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review" International Journal of Molecular Sciences 20, no. 9: 2173.
https://doi.org/10.3390/ijms20092173
APA Style
Chicas-Sett, R., Morales-Orue, I., Castilla-Martinez, J., Zafra-Martin, J., Kannemann, A., Blanco, J., Lloret, M., & Lara, P. C.
(2019). Stereotactic Ablative Radiotherapy Combined with Immune Checkpoint Inhibitors Reboots the Immune Response Assisted by Immunotherapy in Metastatic Lung Cancer: A Systematic Review. International Journal of Molecular Sciences, 20(9), 2173.
https://doi.org/10.3390/ijms20092173
